NCT03148730

Brief Summary

This study will be the first study to report the combined use of three independent closed-loop systems together to assist clinicians in titrating anesthesia, analgesia, fluid and optimize ventilation in frailty old patients undergoing moderate to high risk surgery. The potential benefits of optimizing the control of these variables by advanced closed loop systems are two-fold. Firstly, this will likely decrease the variance of delivered care and reduce deviation from the established standards, resulting in improved post operative cognitive outcomes in elderly patients. Secondly, this would establish a precedent that automated intraoperative systems have strong clinical significance and are more than "complicated toys", which is unfortunately how they are perceived now. Hypothesis: Automated control of anesthetic depth (minimal episodes of overly deep or light anesthesia) and hemodynamics (via improved volume administration) can decrease the occurrence of postoperative cognitive dysfunction in elderly patients undergoing moderate to high risk surgery (Better MOCA test in the postoperative period compared to the manual group \[+ two points in average\])

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 1, 2017

Completed
9 days until next milestone

Study Start

First participant enrolled

May 10, 2017

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 11, 2017

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 21, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 21, 2017

Completed
Last Updated

January 28, 2020

Status Verified

January 1, 2020

Enrollment Period

7 months

First QC Date

May 1, 2017

Last Update Submit

January 26, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Incidence of postoperative cognitive dysfunction (POCD)

    assessment of the POCD using the MOCA test ( done by a psychiatrist and a psychologist). This will be done preoperatively, at postoperative day 3-5 for moderate risk surgery and postoperative day 7-10 for high risk surgery

    first month

Secondary Outcomes (19)

  • Assesment of the incidence of POCD using different others tests:

    Before Surgery

  • Assesment of the incidence of POCD using different others tests:

    day 5 after surgery

  • Assesment of the incidence of POCD using different others tests:

    day 10 after surgery

  • Long term incidence of POCD

    month 3 post surgery

  • Assessment of the Quality of life EQ-5D-5L

    3 months

  • +14 more secondary outcomes

Study Arms (2)

manual group

NO INTERVENTION

This group will have a standard of care anesthesia. All the drugs, fluid and adjustement of ventilation settings will be done manually by the supervising anesthesiologist using the same drugs and fluids as the closed-loop group

automated closed-loop group

EXPERIMENTAL

This group will have a fully automated anesthesia, analgesia , ventilation and fluid management using 3 indenpendent closed-loop systems same drugs used in both groups ( propofol and remifentanil, Plasmalyte and /or Voluven)

Device: closed-loop group

Interventions

Use of 3 indenpendent closed-loop systems to deliver the propofol, remifentanil, fluid and to adjust ventilation

automated closed-loop group

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients \> or equal 60 years old
  • ASA score I-III
  • Scheduled for non cardiac surgery under total intravenous anesthesia
  • Self sufficient (living at home or in non medical institution)
  • MOCA test preop \> 23/30
  • No Stroke, alzeihmer, Parkinson disease
  • Written informed consent signed

You may not qualify if:

  • Allergy to propofol or remifentanil
  • MOCA test \< 23/30
  • Visual or hearing deficiency
  • Atrial fibrillation, or other Contra indication to the use of dynamic parameters of fluid responsiveness.
  • Chronic renal failure ( creatinin level maximum at 2 mg/ml; no dialysis)
  • Large liver resection : our center has a strict fluid /CVP fluid restriction in place

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Erasme

Brussels, 1070, Belgium

Location

MeSH Terms

Conditions

Emergence Delirium

Condition Hierarchy (Ancestors)

DeliriumConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsNeurocognitive DisordersMental Disorders

Study Officials

  • Alexandre Joosten, M.D

    Erasme

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
single blinded ( outcome assessor)
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: 2 groups one = manually conducted anesthesia second = fully automated anesthesia, analgesia, ventilation and fluid management
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 1, 2017

First Posted

May 11, 2017

Study Start

May 10, 2017

Primary Completion

November 21, 2017

Study Completion

November 21, 2017

Last Updated

January 28, 2020

Record last verified: 2020-01

Locations